The recognition and endoscopic treatment of early gastric and colonic cancer

doi:10.1053/bega.2000.0176

Best Practice & Research Clinical Gastroenterology

Volume 15, Issue 2, April 2001, Pages 317-336

https://doi.org/10.1053/bega.2000.0176 Get rights and content

Abstract

As the prognosis of both gastric and colonic cancer remains poor, the challenge is to detect lesions at an early and treatable stage. The benefit of early detection is not only improved survival, but also that patients may be treated with endoscopic mucosal resection, a low-cost, low-morbidity and low-mortality alternative to surgery. In spite of the increasing use of endoscopy in the West, we are not detecting as many early cancers as in Japan. This chapter will discuss the possible reasons for this discrepancy and give a practical guide to ‘Japanese endoscopy techniques’. Finally, we have compiled a comprehensive review of the indications, techniques and complications of endoscopic mucosal resection. Throughout the chapter, controversies have been highlighted to give an insight into the limits of our knowledge and stimulate future research.

References (101)

SM Everett et al.
Early gastric cancer: disease or pseudo-disease?
Lancet
(1998)
JD Hardcastle et al.
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Lancet
(1996)
M Karita et al.
Endoscopic therapy for early colon cancer: the strip biopsy resection technique
Gastrointestinal Endoscopy
(1991)
SJ Stryker et al.
Natural history of untreated colonic polyps
Gastroenterology
(1987)
S Kudo et al.
The problem of de novo colorectal carcinoma
European Journal of Cancer
(1995)
E Jaramillo et al.
Endoscopic detection and complete removal of a micro-invasive carcinoma present in a flat colonic adenoma
Gastrointestinal Endoscopy
(1994)
BJ Rembacken et al.
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK
Lancet
(2000)
T Sawada et al.
Colonoscopic management of focal and early colorectal carcinoma
Baillière's Clinical Gastroenterology
(1989)
T Fujii et al.
Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial
Gastrointestinal Endoscopy
(1998)
E Jaramillo et al.
Flat neoplastic lesions of the colon and rectum detected by high-resolution video endoscopy and chromoscopy
Gastrointestinal Endoscopy
(1995)

S Kudo et al.

Diagnosis of colorectal tumorous lesions by magnifying endoscopy

Gastrointestinal Endoscopy

(1996)

F Perri et al.

Minute and small early gastric cancers in a Western population: a clinicopathologic study on 80 cases

Digestive Diseases and Sciences

(1995)

S Tanabe et al.

Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer

Gastrointestinal Endoscopy

(1999)

T Gotoda et al.

A new endoscopic mucosal resection procedure using an insulation-tipped diathermic knife for rectal flat lesions

Gastrointestinal Endoscopy

(1999)

S Tanabe et al.

Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer

Gastrointestinal Endoscopy

(1999)

Y Uno et al.

The non-lifting sign of invasive cancer

Gastrointestinal Endoscopy

(1994)

M Nishi et al.

Japanese Research Society for Gastric Cancer, Japanese Classification of Gastric Carcinoma

(1995)

L Mountney et al.

Colorectal cancer

Guidance on Commissioning Cancer Services. Improving Outcomes in Colorectal Cancer

(1997)

HM Sue-Ling et al.

Early gastric cancer: 46 cases in one surgical department

Gut

(1992)

H Yamazaki et al.

A long-term follow up study of patients with gastric cancer detected by mass screening

Cancer

(1989)

J Moreaux et al.

Carcinoma of the colon: long-term survival and prognosis after surgical treatment in a series of 798 patients

World Journal of Surgery

(1987)

T Murakami

Pathomorphological diagnosis. Definition and gross classification of early gastric cancer

Gann Monograms in Cancer Research

(1971)

General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus

(1998)

S Shimuzu et al.

Early gastric cancer: its surveillance and natural course

Endoscopy

(1995)

KC Ballantyne et al.

Accuracy of identification of early gastric cancer

British Journal of Surgery

(1987)

H Shida et al.

Asymptomatic colorectal cancer detected by screening

Diseases of the Colon and Rectum

(1996)

K Kitamura et al.

Clinical outcome of surgical treatment for invasive early colorectal cancer in Japan

Hepato-gastroenterology

(1997)

GA Smith et al.

Frequency of early colorectal cancer in patients undergoing colonoscopy

British Journal of Surgery

(1999)

L Kalra et al.

Open access fibre sigmoidoscopy: a comparative audit of efficiency

British Medical Journal

(1988)

J Moreaux et al.

Early gastric cancer. A 25 year surgical experience

Annals of Surgery

(1993)

JJ Bonenkamp et al.

Extended lymph-node dissection for gastric cancer

New England Journal of Medicine

(1999)

Guidelines for the Management of Colorectal Cancer

(1996)

Y Ichiyoshi et al.

Recurrence in early gastric cancer

Surgery

(1990)

T Sano et al.

Lymph node metastasis from early gastric cancer: endoscopic resection of tumor

British Journal of Surgery

(1992)

T Yamao et al.

Risk factors for lymph node metastasis from intramucosal gastric carcinoma

Cancer

(1996)

H Tsukum et al.

Prospective study of ‘early’ gastric cancer

Journal of Cancer

(1983)

S Kudo

Endoscopic mucosal resection of flat and depressed types of early colorectal cancer

Endoscopy

(1993)

T Yokota et al.

Endoscopic mucosal resection for colorectal neoplastic lesions

Diseases of the Colon and Rectum

(1994)

M Nishi et al.

Chronological changes of characteristics of early gastric cancer and therapy: experience in the Cancer Institute Hospital of Tokyo, 1950–1994

Journal of Cancer Research and Clinical Oncology

(1995)

SM Everett et al.

Early gastric cancer in Europe

Gut

(1997)

G Biasco et al.

Early gastric cancer in Italy. Clinical and pathological observations on 80 cases

Digestive Diseases and Sciences

(1987)

KJ Carter et al.

Early gastric cancer

Annals of Surgery

(1984)

DR Farley et al.

Early gastric cancer

British Journal of Surgery

(1992)

H Ono et al.

Endoscopic mucosal resection for treatment of early gastric cancer

Gut

(2001)

BC Morson

Precancerous and early malignant lesions of the large intestine

British Journal of Surgery

(1968)

RJ Jackman et al.

The adenoma–carcinoma sequence in cancer of the colon

Surgery, Gynecology and Obstetrics

(1951)

BC Morson

Factors influencing the pathogenesis of early cancer of the rectum

Proceedings of the Royal Society of Medicine

(1966)

B Morson

The polyp-cancer sequence in the large bowel

Proceedings of the Royal Society of Medicine

(1974)

DE Fleischer et al.

Detection and surveillance of colorectal cancer

Journal of the American Medical Association

(1989)

Cited by (32)

Alginate Containing Nanoarchitectonics for Improved Cancer Therapy
2016, Nanoarchitectonics for Smart Delivery and Drug Targeting
Nanomedicines have gained more and more attention in cancer therapy thanks to their ability to augment tumor accumulation and the intracellular uptake of drugs in ways that reduce their inactivation and toxicity. Advances in polymer science have contributed to novel, nanoscale-targeting approaches that may bring new hope to cancer patients. Alginate is a nontoxic, biocompatible, and biodegradable natural polymer with a number of peculiar physicochemical properties. It is also plentiful in nature, renewable, nontoxic, and comparatively inexpensive. An alginate-based nanocarrier system can provide delivery of therapeutic agents for cancer therapy. This chapter introduces the properties of an alginate nanocarrier, its method of preparation, and the diverse drug-delivery system of the alginate nanocarrier.
Essence of affinity and specificity of peanut agglutinin-immobilized fluorescent nanospheres with surface poly(N-vinylacetamide) chains for colorectal cancer
2011, European Journal of Pharmaceutics and Biopharmaceutics
We have designed a novel colonoscopic imaging agent that is composed of submicron-sized fluorescent polystyrene nanospheres with two functional groups – peanut agglutinin (PNA) and poly(N-vinylaceamide) (PNVA) – on their surfaces. PNA is a targeting moiety that binds to β-d-galactosyl-(1-3)-N-acetyl-d-galactosamine (Gal-β(1-3)GalNAc), which is the terminal sugar of the Thomsen–Friedenreich antigen that is specifically expressed on the mucosal side of colorectal cancer cells; it is anchored on the nanosphere surface via a poly(methacrylic) acid (PMAA) linker. PNVA is immobilized to enhance the specificity of PNA by reducing nonspecific interactions between the imaging agent and normal tissues. The essential nature of both functional groups was evaluated through in vivo experiments using PNA-free and PNVA-free nanospheres. The imaging agent recognized specifically tumors on the cecal mucosa of immune-deficient mice in which human colorectal cancer cells had been implanted; however, the recognition capability disappeared when PNA was replaced with wheat germ agglutinin, which has no affinity for Gal-β(1-3)GalNAc. PNA-free nanospheres with exclusively surface PNVA chains rarely adhered to the cecal mucosa of normal mice that did not undergo the cancer cell implantation. In contrast, there were strong nonspecific interactions between normal tissues and PNA-free nanospheres with exclusively surface PMAA chains. In vivo data proved that PNA and PNVA were essential for biorecognition for tumor tissues and a reduction of nonspecific interactions with normal tissues, respectively.
A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy
2011, European Journal of Pharmaceutical Sciences
Citation Excerpt :
The cancer that remains in the mucous membrane or only minimally invades the submucosal tissues without vessel invasion is often treated by resection using endoscopy. This minimally invasive operation, known as endoscopic mucosal resection (EMR), can serve as an alternative to surgical resection in the early stage of the cancer (Ponchon, 2001; Kudo et al., 2001; Rembacken et al., 2001). While the colonoscopy procedure is critically important, standard white-light colonoscopy has a major limitation: it can only detect tumor tissues that are larger than ca. 1 cm in size.
We designed peanut agglutinin (PNA)-immobilized fluorescent nanospheres as a non-absorbable endoscopic imaging agent capable of being administered intracolonically. Following our previous researches with evidence that the imaging agent recognized small-sized colorectal tumors on the mucosal surface with high affinity and specificity in animal experiments, a potential of this nanoprobe as a drug candidate was evaluated from a safety perspective. The imaging agent detects colorectal tumors through recognition of the tumor-specific antigen by PNA immobilized on the nanosphere surface, and the detection is made via the fluorescent signal derived from coumarin 6 encapsulated into the nanosphere core. The stability studies revealed that the high activity of PNA was maintained and there was no significant leakage of coumarin 6 after intracolonic administration of the imaging agent. Cytotoxicity studies indicated that no local damage to the large intestinal membrane was induced by the imaging agent. Further, in vitro and in vivo permeation studies demonstrated that there was no significant permeation of the imaging agent through the monolayer of cultured cells and that the imaging agent administered locally to the luminal side of the large intestine was almost completely recovered from the administration site. Therefore, we concluded that the imaging agent is a safe and stable probe which remains in the large intestine without systemic exposure.
Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms
2011, Biomaterials
Citation Excerpt :
The incidence of colorectal cancer is increasing worldwide, and its prognosis remains poor [1].
Colorectal cancer is one of the leading causes of cancer death and often goes undetected with current colonoscopy practices. Improved methods of detecting dysplasia and tumors during colonoscopy could significantly improve mortality. Herein, we report a high-performance nanoparticle for photodynamic detection of colorectal cancer, where alginate is physically complexed with folic acid-modified chitosan to form nanoparticles with improved drug release in the cellular lysosome. The incorporated alginate molecules could complex stably with chitosan via electrostatic attraction, and the z-average diameter and zeta-potential of the prepared nanoparticles (fCAN) was 115 nm and 22 mV, respectively, enough to keep the nanoparticles stable in aqueous suspension without aggregation. When loaded with 5-aminolevulinic acid (5-ALA; 27% loading efficiency), the nanoparticles (fCANA) displayed no differences in particle size or zeta-potential compared to fCAN. Moreover, the fCANA nanoparticles were readily taken up by colorectal cancer cells via folate receptor-mediated endocytosis. Subsequently, the loaded 5-ALA was release in the lysosome, and this was promoted by the reduced attraction intensity between chitosan and 5-ALA via the deprotonated alginate, resulting in a higher intracellular PpIX accumulation for the photodynamic detection. These studies demonstrate that the alginate incorporated and folic acid-conjugated chitosan nanoparticles are excellent vectors for colorectal-specific delivery of 5-ALA for fluorescent endoscopic detection.
Detection of early colorectal cancer imaged with peanut agglutinin-immobilized fluorescent nanospheres having surface poly(N-vinylacetamide) chains
2010, European Journal of Pharmaceutics and Biopharmaceutics
Peanut agglutinin (PNA)-immobilized fluorescent nanospheres were designed as a novel imaging agent for colonoscopy. PNA is a targeting moiety that binds to β-d-galactosyl-(1–3)-N-acetyl-d-galactosamine, which is the terminal sugar of the Thomsen-Friedenreich antigen that is specifically expressed on the mucosal side of colorectal cancer cells. The in vivo performance of the imaging agent was evaluated using a human colorectal cancer orthotopic animal model. Human colorectal adenocarcinoma cell lines, HT-29, HCT-116, and LS174T, were implanted on the cecal serosa of immune-deficient mice. A loop of the tumor-bearing cecum was made, and the luminal side was treated with the imaging agent. Strong fluorescence was observed at several sites of the cecal mucosa, irrespective of cancer cell type. Microscopic histological evaluation of the cecal mucosa revealed that bright areas with fluorescence derived from the imaging agent and dark areas without the fluorescence well denoted the presence and absence, respectively, of the invasion of implanted cancer cells on the mucosal side. This good correlation showed that PNA-immobilized fluorescent nanospheres recognized millimeter-sized tumors on the cecal mucosa with high affinity and specificity.
In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells
2009, Journal of Controlled Release
Peanut agglutinin (PNA)-immobilized polystyrene nanospheres with surface poly(N-vinylacetamide) (PNVA) chains encapsulating coumarin 6 were designed as a novel colonoscopic imaging agent. PNA was a targeting moiety that binds to β-d-galactosyl-(1-3)-N-acetyl-d-galactosamine, which is the terminal sugar of the Thomsen–Friedenreich antigen that is specifically expressed on the mucosal side of colorectal cancer cells. PNVA was immobilized with the aim of reducing nonspecific interactions between imaging agents and normal tissues. Coumarin 6 was encapsulated into nanosphere cores to provide endoscopically detectable fluorescence intensity. After incubation of imaging agents with human cells, the fluorescence intensity of imaging agent-bound cells was estimated quantitatively. The average fluorescence intensity of any type of colorectal cancer cell used in this study was higher than that of small intestinal epithelial cells that had not exposed the carbohydrate. The in vivo performance of imaging agents was subsequently evaluated using a human colorectal cancer orthotopic animal model. Imaging agent-derived strong fluorescence was observed at several sites of the large intestinal mucosa in the tumor-implanted nude mice after the luminal side of the colonic loop was contacted with imaging agents. In contrast, when mice that did not undergo tumor implantation were used, the fluorescence intensity on the mucosal surface was extremely low. Data indicated that imaging agents bound to colorectal cancer cells and the cancer cell-derived tumors with high affinity and specificity.

View all citing articles on Scopus

View full text

Regular ArticleThe recognition and endoscopic treatment of early gastric and colonic cancer

Abstract

Lancet

Lancet

Gastrointestinal Endoscopy

Gastroenterology

European Journal of Cancer

Gastrointestinal Endoscopy

Lancet

Baillière's Clinical Gastroenterology

Gastrointestinal Endoscopy

Gastrointestinal Endoscopy

Gastrointestinal Endoscopy

Digestive Diseases and Sciences

Gastrointestinal Endoscopy

Gastrointestinal Endoscopy

Gastrointestinal Endoscopy

Gastrointestinal Endoscopy

Japanese Research Society for Gastric Cancer, Japanese Classification of Gastric Carcinoma

Colorectal cancer

Guidance on Commissioning Cancer Services. Improving Outcomes in Colorectal Cancer

Early gastric cancer: 46 cases in one surgical department

Gut

A long-term follow up study of patients with gastric cancer detected by mass screening

Cancer

Carcinoma of the colon: long-term survival and prognosis after surgical treatment in a series of 798 patients

World Journal of Surgery

Pathomorphological diagnosis. Definition and gross classification of early gastric cancer

Gann Monograms in Cancer Research

General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus

Early gastric cancer: its surveillance and natural course

Endoscopy

Accuracy of identification of early gastric cancer

British Journal of Surgery

Asymptomatic colorectal cancer detected by screening

Diseases of the Colon and Rectum

Clinical outcome of surgical treatment for invasive early colorectal cancer in Japan

Hepato-gastroenterology

Frequency of early colorectal cancer in patients undergoing colonoscopy

British Journal of Surgery

Open access fibre sigmoidoscopy: a comparative audit of efficiency

British Medical Journal

Early gastric cancer. A 25 year surgical experience

Annals of Surgery

Extended lymph-node dissection for gastric cancer

New England Journal of Medicine

Guidelines for the Management of Colorectal Cancer

Recurrence in early gastric cancer

Surgery

Lymph node metastasis from early gastric cancer: endoscopic resection of tumor

British Journal of Surgery

Risk factors for lymph node metastasis from intramucosal gastric carcinoma

Cancer

Prospective study of ‘early’ gastric cancer

Journal of Cancer

Endoscopic mucosal resection of flat and depressed types of early colorectal cancer

Endoscopy

Endoscopic mucosal resection for colorectal neoplastic lesions

Diseases of the Colon and Rectum

Chronological changes of characteristics of early gastric cancer and therapy: experience in the Cancer Institute Hospital of Tokyo, 1950–1994

Journal of Cancer Research and Clinical Oncology

Early gastric cancer in Europe

Gut

Early gastric cancer in Italy. Clinical and pathological observations on 80 cases

Digestive Diseases and Sciences

Early gastric cancer

Annals of Surgery

Early gastric cancer

British Journal of Surgery

Endoscopic mucosal resection for treatment of early gastric cancer

Gut

Precancerous and early malignant lesions of the large intestine

British Journal of Surgery

The adenoma–carcinoma sequence in cancer of the colon

Surgery, Gynecology and Obstetrics

Factors influencing the pathogenesis of early cancer of the rectum

Proceedings of the Royal Society of Medicine

The polyp-cancer sequence in the large bowel

Proceedings of the Royal Society of Medicine

Detection and surveillance of colorectal cancer

Regular Article
The recognition and endoscopic treatment of early gastric and colonic cancer